AKRO Smart Money
Akero Therapeutics, Inc.
1W: +0.3%
1M: +1.1%
3M: +26.4%
1Y: +84.0%
3Y: +20.2%
5Y: +93.0%
$54.65
Last traded 2025-12-09 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
🏦 Institutional Activity
Latest: Q1 20262
Institutions Holding
-260 vs prior
0.0%
Ownership
+0.00%
0
New
0
Increased
2
Reduced
2
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025-12-09 | Young Jonathan | officer: chief operating officer | D-Sale to Issuer | 152,616 | $— | $0 | Filing |
| 2025-12-09 | Harrison Seth Loring | director | D-Sale to Issuer | 136,301 | $— | $0 | Filing |
| 2025-12-09 | Young Jonathan | officer: chief operating officer | D-Sale to Issuer | 47,573 | $— | $0 | Filing |
| 2025-12-09 | Henderson Jane | director | D-Sale to Issuer | 9,398 | $— | $0 | Filing |
| 2025-12-09 | Lamy Patrick | officer: see remarks | D-Sale to Issuer | 3,059 | $— | $0 | Filing |
| 2025-12-09 | Lamy Patrick | officer: see remarks | D-Sale to Issuer | 26,832 | $— | $0 | Filing |
| 2025-12-09 | Yale Catriona | officer: chief development officer | D-Sale to Issuer | 27,227 | $— | $0 | Filing |
| 2025-12-09 | Young Jonathan | officer: chief operating officer | D-Sale to Issuer | 20,000 | $— | $0 | Filing |
| 2025-12-09 | White William Richard | officer: chief financial officer | D-Sale to Issuer | 10,179 | $— | $0 | Filing |
| 2025-12-09 | White William Richard | officer: chief financial officer | D-Sale to Issuer | 47,573 | $— | $0 | Filing |
| 2025-12-09 | Gangloff Scott A. | officer: chief technology officer | D-Sale to Issuer | 5,088 | $— | $0 | Filing |
| 2025-12-09 | Gangloff Scott A. | officer: chief technology officer | D-Sale to Issuer | 21,263 | $— | $0 | Filing |
| 2025-12-09 | Iwicki Mark T | director | D-Sale to Issuer | 9,398 | $— | $0 | Filing |
| 2025-12-09 | Rolph Timothy | officer: chief scientific officer | D-Sale to Issuer | 238,339 | $— | $0 | Filing |
| 2025-12-09 | Rolph Timothy | officer: chief scientific officer | D-Sale to Issuer | 43,810 | $— | $0 | Filing |
| 2025-12-09 | Judy Chou | director | D-Sale to Issuer | 9,398 | $— | $0 | Filing |
| 2025-12-09 | Graham G. Walmsley | director | D-Sale to Issuer | 93,000 | $— | $0 | Filing |
| 2025-12-09 | Graham G. Walmsley | director | D-Sale to Issuer | 1,200,000 | $— | $0 | Filing |
| 2025-12-09 | Graham G. Walmsley | director | D-Sale to Issuer | 9,398 | $— | $0 | Filing |
| 2025-12-09 | Xu Yuan | director | D-Sale to Issuer | 9,398 | $— | $0 | Filing |
| 2025-12-09 | Harrison Seth Loring | director | D-Sale to Issuer | 148,063 | $— | $0 | Filing |
| 2025-12-09 | Harrison Seth Loring | director | D-Sale to Issuer | 9,398 | $— | $0 | Filing |
| 2025-12-09 | Cheng Andrew | officer: president and ceo | D-Sale to Issuer | 277,075 | $— | $0 | Filing |
| 2025-12-09 | Cheng Andrew | officer: president and ceo | D-Sale to Issuer | 159,762 | $— | $0 | Filing |
| 2025-12-09 | Yale Catriona | officer: chief development officer | D-Sale to Issuer | 47,573 | $— | $0 | Filing |
🏛️ Congressional Trades
1 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2022-11-08 | Chris Jacobs | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
2 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 0 | $0K | -20,000 | 2026-03-31 | Filing |
| IFP Advisors, Inc | 0 | $0K | -18 | 2026-03-31 | Filing |